The American Chemical Society (ACS) has announced that internationally renowned chemist Dr. Carolyn Bertozzi will take the helm as editor-in-chief of its first fully open access journal, ACS Central Science, which is set to launch in early 2015. Currently a Howard Hughes Medical Institute (HHMI) investigator at the University of California at Berkeley, Bertozzi is widely recognized as one of the most accomplished and respected chemists of her generation.
The term 'central science,' coined some 40 years ago, is commonly used to describe the focal role of chemistry in bridging the physical and life sciences, as well as the basic sciences, with applied disciplines like medicine and engineering. ACS Central Science will publish exceptional, peer-reviewed research articles, reviews and commentary across the broad spectrum of chemistry and interdisciplinary sciences. There will be no restrictions on access to the full text of the articles.
Bertozzi's research focuses on creating new technologies for the development of medicines and diagnostics that will improve human health. This work spans a number of technologies and approaches at the interface of chemistry and biology.
In addition to being an HHMI investigator, Bertozzi is co-director of the University of California at Berkeley Chemical Biology Graduate Program, co-director of the Berkeley Nanosciences and Nanoengineering Institute, a professor at the University of California at San Francisco and a senior faculty scientist at Lawrence Berkeley National Laboratory. In April 2015, she will move to Stanford University as professor of chemistry and a member of Stanford's new ChEM-H (Chemistry, Engineering and Medicine for Human Health) institute.
More News in this Theme
